MedTrace Logo

Inflammatory Response as a Prognostic Factor of Recurrence of Atrial Fibrillation After Ablation

NCT02844959 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2016-07-26

No results posted yet for this study

Summary

The aim of this study is to evaluate inflammatory response as a prognostic factor of atrial fibrillation recurrency after ablation. Inflammatory response will be assessed by double measurement of C-reactive protein, fibroblast growth factor 2 (FGF2), matrix metallopeptidase 8 (MMP8) and body temperature. Dynamics of change of troponin I will be measured additionally.

After ablation each patient will be monitored with ECG telemonitoring system for 7 days.

Conditions

Sponsors & Collaborators

  • Medical University of Warsaw

    lead OTHER

Principal Investigators

  • Marcin D Grabowski, PhD · 1st Department of Cardiology Medical University of Warsaw

  • Paweł Balsam, PhD · 1st Department of Cardiology Medical University of Warsaw

  • Piotr Lodziński, PhD · 1st Department of Cardiology Medical University of Warsaw

  • Grzegorz Opolski, Professor · 1st Department of Cardiology Medical University of Warsaw

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-07-31
Completion
2018-07-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02844959 on ClinicalTrials.gov